ArticleCancer immunology, immunotherapy : CII2022

Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.

Staffan Holmberg-Thydén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.